Skip to main content
PMC home page
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1992 Dec;19:S46–S53.

Myths and realities of antiemetic treatment.

M Martin 1
PMCID: PMC2149635  PMID: 1467202

Full text

PDF
S46

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abad-Esteve A., Rosell R., Moreno I., Monrás P., Fernández C., Serichol M., Clotet M., Ribas Mundó M. Valoración del régimen antiemético con combinación de altas dosis de metoclopramida, dexametasona y difenhidramina en regímenes de quimioterapia con cisplatino. Med Clin (Barc) 1986 Dec 6;87(19):796–798. [PubMed] [Google Scholar]
  2. Allan S. G., Farquhar D. F., Harrison D. J., Leonard R. C. Anti-emetic efficacy of dexamethasone in combination for out-patients receiving cytotoxic chemotherapy. Cancer Chemother Pharmacol. 1986;18(1):86–87. doi: 10.1007/BF00253072. [DOI] [PubMed] [Google Scholar]
  3. Carr B. I., Bertrand M., Browning S., Doroshow J. H., Presant C., Pulone B., Hill L. R. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study. J Clin Oncol. 1985 Aug;3(8):1127–1132. doi: 10.1200/JCO.1985.3.8.1127. [DOI] [PubMed] [Google Scholar]
  4. Chang J., Geary C. G. Therapy-linked leukemia. Lancet. 1977 Jan 8;1(8002):97–97. doi: 10.1016/s0140-6736(77)91113-8. [DOI] [PubMed] [Google Scholar]
  5. Cognetti F., Carlini P., Pinnarò P., Ruggeri E. M., Caporali C. Maintenance of antiemetic effect of a metoclopramide-dexamethasone combination during subsequent cisplatin courses. Oncology. 1986;43(5):292–294. doi: 10.1159/000226385. [DOI] [PubMed] [Google Scholar]
  6. Fetting J. H., Grochow L. B., Folstein M. F., Ettinger D. S., Colvin M. The course of nausea and vomiting after high-dose cyclophosphamide. Cancer Treat Rep. 1982 Jul;66(7):1487–1493. [PubMed] [Google Scholar]
  7. Gralla R. J., Itri L. M., Pisko S. E., Squillante A. E., Kelsen D. P., Braun D. W., Jr, Bordin L. A., Braun T. J., Young C. W. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med. 1981 Oct 15;305(16):905–909. doi: 10.1056/NEJM198110153051601. [DOI] [PubMed] [Google Scholar]
  8. Grunberg S. M., Gala K. V., Lampenfeld M., Jamin D., Johnson K., Cariffe P., Strych D., Krailo M. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study. J Clin Oncol. 1984 Jul;2(7):782–787. doi: 10.1200/JCO.1984.2.7.782. [DOI] [PubMed] [Google Scholar]
  9. Hesketh P. J., Murphy W. K., Lester E. P., Gandara D. R., Khojasteh A., Tapazoglou E., Sartiano G. P., White D. R., Werner K., Chubb J. M. GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis. J Clin Oncol. 1989 Jun;7(6):700–705. doi: 10.1200/JCO.1989.7.6.700. [DOI] [PubMed] [Google Scholar]
  10. Jacobs A. J., Deppe G., Cohen C. J. A comparison of the antiemetic effects of droperidol and prochlorperazine in chemotheray with cis-platinum. Gynecol Oncol. 1980 Aug;10(1):55–57. doi: 10.1016/0090-8258(80)90063-3. [DOI] [PubMed] [Google Scholar]
  11. Kris M. G., Gralla R. J., Clark R. A., Tyson L. B., O'Connell J. P., Wertheim M. S., Kelsen D. P. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol. 1985 Oct;3(10):1379–1384. doi: 10.1200/JCO.1985.3.10.1379. [DOI] [PubMed] [Google Scholar]
  12. Kris M. G., Gralla R. J., Tyson L. B., Clark R. A., Cirrincione C., Groshen S. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol. 1989 Jan;7(1):108–114. doi: 10.1200/JCO.1989.7.1.108. [DOI] [PubMed] [Google Scholar]
  13. Kris M. G., Gralla R. J., Tyson L. B., Clark R. A., Kelsen D. P., Reilly L. K., Groshen S., Bosl G. J., Kalman L. A. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients. Cancer. 1985 Feb 1;55(3):527–534. doi: 10.1002/1097-0142(19850201)55:3<527::aid-cncr2820550310>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  14. Martin-Jimenez M., Diaz-Rubio E., Sangro B., Marote R. Laparotomic eventration or colonic prolapse after chemotherapy-induced emesis. J Surg Oncol. 1988 Mar;37(3):204–206. doi: 10.1002/jso.2930370315. [DOI] [PubMed] [Google Scholar]
  15. Martin M., Diaz-Rubio E., Sánchez A., Almenarez J., López-Vega J. M. The natural course of emesis after carboplatin treatment. Acta Oncol. 1990;29(5):593–595. doi: 10.3109/02841869009090058. [DOI] [PubMed] [Google Scholar]
  16. Marty M., Pouillart P., Scholl S., Droz J. P., Azab M., Brion N., Pujade-Lauraine E., Paule B., Paes D., Bons J. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med. 1990 Mar 22;322(12):816–821. doi: 10.1056/NEJM199003223221205. [DOI] [PubMed] [Google Scholar]
  17. Pollera C. F., Giannarelli D. Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model. Cancer. 1989 Sep 1;64(5):1117–1122. doi: 10.1002/1097-0142(19890901)64:5<1117::aid-cncr2820640525>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  18. Roemeling R. V., Christiansen N. P., Hrushesky W. J. Lack of antiemetic effect of high-dose metoclopramide. J Clin Oncol. 1985 Sep;3(9):1273–1276. doi: 10.1200/JCO.1985.3.9.1273. [DOI] [PubMed] [Google Scholar]
  19. Roila F., Tonato M., Basurto C., Picciafuoco M., Bracarda S., Donati D., Malacarne P., Monici L., Di Costanzo F., Patoia L. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research. J Clin Oncol. 1989 Nov;7(11):1693–1700. doi: 10.1200/JCO.1989.7.11.1693. [DOI] [PubMed] [Google Scholar]
  20. Tyson L. B., Clark R. A., Gralla R. J. High-dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial. Cancer Treat Rep. 1982 Dec;66(12):2108–2108. [PubMed] [Google Scholar]
  21. Whitehead V. M. Letter: Cancer treatment needs better antiemetics. N Engl J Med. 1975 Jul 24;293(4):199–200. doi: 10.1056/NEJM197507242930416. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES